© 1990 British Society for Rheumatology
other |
ESTIMATING THE INCIDENCE OF SYSTEMIC LUPUS ERYTHEMATOSUS IN A DEFINED POPULATION USING MULTIPLE SOURCES OF RETRIEVAL
*Department of Rheumatology, University Hospital Lund, Sweden
ARC Epidemiology Research Unit, Manchester University Medical School Manchester, England
Correspondence to:
Correspondence to Dr O. Nived, Department of Rheumatology, University Hospital, S-221 85 Lund, Sweden
We studied the age-specific incidence of SLE in a defined population in southern Sweden during 1981-86. Female incidence was 5.4/100 000/year and male incidence 1/100 000/year. In comparison with previous studies, incident cases were characterized by a high age at diagnosis with the highest incidence in age groups 55-64 and 65-74, approximately 7.5/100 000/year. The incidence was low in children under 15 years of age, 0.4/100 000/year, and unexpectedly so in the 15-24 decade, 1.2/100 000/year. Patient retrieval was based on four separate sources: a computerized diagnosis register; referrals from both public health care physicians and private practitioners; and records of ANA positive individuals from the single laboratory serving the area. All incident patients were present in at least two of these sources and 11 patients were present in three. We interpret the high amount of overlap between retrieval sources, without patients detected in only one source, as evidence for a high degree of completeness in our retrieval of SLE patients
KEY WORDS: Incidence, Age, Sex, Antinuclear antibody, Retrieval, Diagnostic register, Public health care
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G Bertsias, C Gordon, and D. Boumpas Clinical trials in systemic lupus erythematosus (SLE): lessons from the past as we proceed to the future - the EULAR recommendations for the management of SLE and the use of end-points in clinical trials Lupus, May 1, 2008; 17(5): 437 - 442. [Abstract] [PDF]
|
|
|
|
 |
|
 G Bertsias, J P A Ioannidis, J Boletis, S Bombardieri, R Cervera, C Dostal, J Font, I M Gilboe, F Houssiau, T Huizinga, et al. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics Ann Rheum Dis, February 1, 2008; 67(2): 195 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Nived, M. Andersson, M. Lindgren, P. Malcus-Johnsson, A. Nihlberg, K. Nived, G. Reimer-Rasmusson, G. Sturfelt, C. Stahl-Hallengren, and A.A. Bengtsson Adherence with advice and prescriptions in SLE is mostly good, but better follow up is needed: A study with a questionnaire Lupus, September 1, 2007; 16(9): 701 - 706. [Abstract] [PDF]
|
|
|
|
|
|
N Danchenko, J A Satia, and M S Anthony Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden Lupus, May 1, 2006; 15(5): 308 - 318. [Abstract] [PDF]
|
|
|
|
|
|
C S. Hallengren, O Nived, and G Sturfelt Outcome of incomplete systemic lupus erythematosus after 10 years Lupus, February 1, 2004; 13(2): 85 - 88. [Abstract] [PDF]
|
|
|
|
|
|
K Manger, B Manger, R Repp, M Geisselbrecht, A Geiger, A Pfahlberg, T Harrer, and J R Kalden Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus Ann Rheum Dis, December 1, 2002; 61(12): 1065 - 1070. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Jonsen, A. A. Bengtsson, O. Nived, B. Ryberg, and G. Sturfelt Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality Rheumatology, November 1, 2002; 41(11): 1308 - 1312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M J P. Vilar and E I Sato Estimating the incidence of systemic lupus erythematosus in a tropical region (Natal, Brazil) Lupus, August 1, 2002; 11(8): 528 - 532. [Abstract] [PDF]
|
|
|
|
|
|
A. A. Bengtsson, L. Rylander, L. Hagmar, O. Nived, and G. Sturfelt Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden Rheumatology, May 1, 2002; 41(5): 563 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O Nived, A Bengtsson, A Jonsen, G Sturfelt, and H Olsson Malignancies during follow-up in an epidemiologically defined systemic lupus erythematosus inception cohort in southern Sweden Lupus, July 1, 2001; 10(7): 500 - 504. [Abstract] [PDF]
|
|
|
|
 |
|
 E. C. Janowsky, L. L. Kupper, and B. S. Hulka Meta-Analyses of the Relation between Silicone Breast Implants and the Risk of Connective-Tissue Diseases N. Engl. J. Med., March 16, 2000; 342(11): 781 - 790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Sturfelt, G. Hellmer, and L. Truedsson TNF microsatellites in systemic lupus erythematosus a high frequency of the TNFabc 2-3-1 haplotype in multicase SLE families Lupus, December 1, 1996; 5(6): 618 - 622. [Abstract] [PDF]
|
|
|
|
|
|
M.C. Hochberg, D.L. Perlmutter, T.A. Medsger, V. Steen, M.H. Weisman, B. White, and F.M. Wigley Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA Lupus, December 1, 1995; 4(6): 454 - 456. [Abstract] [PDF]
|
|
|
|
|
|
A.E. Johnson, F.S. Cavalcanti, C. Gordon, O. Nived, R.G. Palmer, G. Sturfelt, N.J. Viner, and P.A. Bacon Cross-Sectional Analysis of the Differences Between Patients with Systemic Lupus Erythematosus in England, Brazil and Sweden Lupus, December 1, 1994; 3(6): 501 - 506. [Abstract] [PDF]
|
|